| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Gains (losses) on extinguishment of debt | - | - | - | -4,145 |
| Investment income, net | - | - | - | 3,280 |
| Income before income taxes | 43,436 | 17,025 | 3,122 | 15,580 |
| Provision for income taxes | 11,929 | 5,042 | 705 | 6,245 |
| Net income | 31,507 | 11,983 | 2,417 | 9,335 |
| Earnings per share, basic | 1 | 0.38 | 0.08 | 0.29 |
| Earnings per share, diluted | 0.84 | 0.34 | 0.07 | 0.27 |
| Weighted average number of shares outstanding, basic | 31,571,410 | 31,810,612 | 31,793,739 | 32,259,468 |
| Weighted average number of shares outstanding, diluted | 39,439,890 | 39,075,703 | 32,840,153 | 40,163,266 |
COLLEGIUM PHARMACEUTICAL, INC (COLL)
COLLEGIUM PHARMACEUTICAL, INC (COLL)